GET FREE SENSEX & NSE TIPS IN YOUR MOBILE PHONE:
9/3/10
Hold Steel Strips Wheels; target of Rs 300: Nirmal Bang - Moneycontrol.com -
“Steel Strips Wheels has sales and profitability to witness a robust growth over next couple of years. At the CMP of Rs 258 per share, SSWL is currently trading at a PE of 10.29x FY11E and looks fairly attractive. Based on the EPS estimate of Rs 25.06 and our target multiple of 12.0x we arrive at a target of Rs 300 for the stock. We initiated coverage on SSWL on 31 May 2010 at Rs 133 with a BUY rating and a target price of Rs 250, indicating a potential upside of 88%. This target has been achieved today. We continue to remain positive on the stock and recommend to HOLD the stock for a target of Rs 300,” says Nirmal Bang research report."
CLICK 2 EARN MONEY : VISIT :STOCKINDIA.SLINKSET.COM>FOR MORE STOCK TIPS AND NEWS****VISIT :BEST EARN MONEY & BEST WEBSITES INFO
Buy Vardhman Textiles; target of Rs 375: IIFL - Moneycontrol.com -
“Vardhman Textiles (VTL), India’s largest yarn manufacturer, is one of the best-placed to benefit from the rise in yarn realisations (up ~60% in 15 months), thanks to a benign cost environment (cotton prices in India are up only 20% in 15 months, thanks to a bumper crop). Continued expansion in EBITDA margins on yarn (>200bps YoY), coupled with the company’s planned capacity expansion by 20%+ over the next two years, should support a re-rating of the stock to 8x 1-year forward PE (near its historical average multiple). Accordingly, we set a 1-year-forward target price of Rs 374 and initiate coverage with a BUY,” says IIFL research report."
CLICK 2 EARN MONEY : VISIT :STOCKINDIA.SLINKSET.COM>FOR MORE STOCK TIPS AND NEWS****VISIT :BEST EARN MONEY & BEST WEBSITES INFO
Buy Piramal Healthcare: Parag Parikh Financial Services - Moneycontrol.com -
“Piramal Healthcare is a 22 year old pharma company, which is one of the earliest players of the Indian Pharma Sector. Through strategic acquisitions in the early years, Piramal Healthcare has built up an enviable position in the Indian Pharma Sector. Their formulations business was purchased by Abbott at 10 times Sales (USD 3.72 billion) whereas their diagnostics business was purchased by SRL at 3 times Sales (Rs 600 crore). The management of Piramal Healthcare has proven its competence over the past couple of decades by making the company into one of the top 3 Pharma businesses in India,” says Parag Parikh Financial Advisory Services research report."
TO BECOME A "CITIZEN JOURNALIST" NO COURSE OR MONEY IS NEEDED! JUST VISIT @ HTTP://NEWZ.GROU.PS NOW .||VISIT FOR MORE LATEST NEWS AND VIDEOS VISIT @ JUSTNEWS.MAGNIFY.NET NOW .||VISIT FOR MORE "BOLLYWOOD NEWS" @ BOLLYNEWS.SLINKSET.COM NOW & ENJOY.||VISIT FOR MORE "LATEST INDIA & WORLD NEWS" @ NEWSNOW.SLINKSET.COM NOW & ENJOY.
VIDEO - See inflation at 7% by March 2011: Shankar Acharya
For more stock tips, news and many more visit STOCKINDIA TIPS WORLD
Earn Credits Worth Rs 50 On Dealivore By Referring Friends And Help Your Friends Get Rs 50 On Dealivore @ WWW.DEALIVORE.COM NOW
From: http://www.youtube.com/watch?v=oTqEw8OK3Sk
VIDEO - New ULIP norms: Insurers expect sharp drop in sales
For more stock tips, news and many more visit STOCKINDIA TIPS WORLD
Earn Credits Worth Rs 50 On Dealivore By Referring Friends And Help Your Friends Get Rs 50 On Dealivore @ WWW.DEALIVORE.COM NOW
From: http://www.youtube.com/watch?v=_6-dQ0MuGNA
Buy Nilkamal; target of Rs 412: Sushil Finance - Moneycontrol.com -
“Nilkamal with a strong market presence and brand value continues to dominate the industry in its plastic business. Going forward, the industry is expected to grow at 12% to 15% and companies like Nilkamal, with its strong brand & national presence, are expected to grow at a much faster pace. On the margins front, the company enjoys EBIDTA margins of around 14%, but after absorbing the loss of at home, margins are a bit lower at around 12%. We expect new product launches, rise in volume growth in the moulded furniture segment and capacity expansion to drive growth going ahead.â€
For more stock tips, news and many more visit STOCKINDIA TIPS WORLD
Earn Credits Worth Rs 50 On Dealivore By Referring Friends And Help Your Friends Get Rs 50 On Dealivore @ WWW.DEALIVORE.COM NOW
From: http://www.moneycontrol.com/news/recommendations/buy-nilkamal-targetrs-412-sushil-finance_482498.html
DAY TRADING TIPS FROM The Business Line : Day Trading Guide
DLF
Make use of rallies to sell the stock with tight stop-loss at Rs 315 levels.
ICICI Bank
Fresh long position can be initiated only if the stock moves beyond Rs 1,012 levels with stiff stop.
Infosys
We recommend a sell in the stock with stiff stop-loss at Rs 2,772 levels.
L&T
Initiate fresh long position if the counter exceeds above Rs 1,856 levels with rigid stop.
ONGC
We recommend a sell in ONGC with stop at Rs 1,334 levels.
Reliance Capital
We recommend a buy in the stock with tight stop-loss at Rs 763 levesl.
Reliance Communications
Utilise rallies to sell the stock while maintaining stiff stop-loss at Rs 165 levels.
Reliance Industries
Initiate fresh long position only if the counter moves above Rs 948 with stiff stop-loss.
SBI
The stock is witnessing selling interest at higher levels. Make use of rallies to sell the stock with tight stop-loss at Rs 2,776 levels.
Nifty Futures
As long as Nifty Futures trades above 5460 levels, the near-term stance remains positive for the session. We recommend a buy with tight stop-loss at 5460 levels.
For more stock tips, news and many more visit STOCKINDIA TIPS WORLD
Earn Credits Worth Rs 50 On Dealivore By Referring Friends And Help Your Friends Get Rs 50 On Dealivore @ WWW.DEALIVORE.COM NOW
From: http://www.thehindubusinessline.com/2010/09/03/stories/2010090353121100.htm
Business Line recommends :Texmaco (Rs 159.1): Buy
We recommend a buy in the stock of Texmaco from a short-term perspective. After finding support in the band between Rs 115 and Rs 120 in late May, the stock reversed higher. The long-term trend is up from its March 2009 low of Rs 35. In early August, the stock breached its 200-day moving average as well as significant intermediate-term resistance at Rs 140 and continued to trend up. The stock is hovering well above its 50- and 200-day moving average. On Thursday, the stock climbed 3.4 per cent, penetrating its near-term resistance level of Rs 155. We notice that there is an increase in volume over the past two trading sessions. The 14-day relative strength index has re-entered in to the bullish zone from the neutral region whereas the weekly RSI is featuring in the bullish zone. Both daily and weekly moving average convergence divergence oscillators are hovering in the positive territory implying upward momentum. Our short-term forecast on the stock is positive. We anticipate it to continue its up-move until it hits our price target of Rs 164 or Rs 169. Short-term traders can buy the stock while maintaining stop-loss at Rs 154.
Yoganand D.
For more stock tips, news and many more visit STOCKINDIA TIPS WORLD
Earn Credits Worth Rs 50 On Dealivore By Referring Friends And Help Your Friends Get Rs 50 On Dealivore @ WWW.DEALIVORE.COM NOW
From: http://www.thehindubusinessline.com/2010/09/03/stories/2010090353111100.htm
Buy Surya Pharma; target of Rs 430: Sunidhi Securities - Moneycontrol.com -
“Surya Pharmaceutical (SPL) has recently entered the business of manufacturing menthol and its derivatives. Menthol is a synthetic product with a wide array of applications in the pharmaceutical industry and the fast moving consumer goods (FMCG) industry. SPL is one of the largest exporters of mint/menthol derivatives and manages state of the art R & D centers that offer the highest quality of CRAMS services. SPL continued to maintain an upward, growing and successful track record and has well positioned in domestic as well as international market. SPL’s recently completed and ongoing expansion is likely to contribute handsomely to the revenue & profitability in the future. SPL is likely to post an EPS of Rs 69 in FY11 and Rs 95 in FY12. At the CMP of Rs 284, the share is trading at a P/E of 4.1x on FY11E and 3.0x on FY12E. We recommend BUY with a target of Rs 430 in the medium-to-long term,†says Sunidhi Securities research report.
For more stock tips, news and many more visit STOCKINDIA TIPS WORLD
Earn Credits Worth Rs 50 On Dealivore By Referring Friends And Help Your Friends Get Rs 50 On Dealivore @ WWW.DEALIVORE.COM NOW
From: http://www.moneycontrol.com/news/recommendations/buy-surya-pharma-targetrs-430-sunidhi-securities_482515.html
Buy Visa Steel; target of Rs 52: Networth Stock Broking - Moneycontrol.com -
“VISA Steel, a part of Rs 5000 crore VISA Group, is an emerging integrated specialty steel company. It is engaged in the manufacturing of pig iron, lam coke, ferro chrome, sponge iron, captive power and soon entering into special steel products with its operations in Orissa and Chhattisgarh. Currently the stock is quoting at 8.4x on TTM EPS of Rs 4.2. We give BUY rating on Visa Steel Limited at current levels with FY12 price target of Rs 52, an upside of 47%,†says Networth Stock Broking research report.
For more stock tips, news and many more visit STOCKINDIA TIPS WORLD
Earn Credits Worth Rs 50 On Dealivore By Referring Friends And Help Your Friends Get Rs 50 On Dealivore @ WWW.DEALIVORE.COM NOW
From: http://www.moneycontrol.com/news/recommendations/buy-visa-steel-targetrs-52-networth-stock-broking_482643.html
Buy Solar Industries India; target of Rs 52: KRChoksey - Moneycontrol.com -
“Solar Industries has traded in forward PE band of 5.40x- 21.45x. There is visible and secular growth potential for the company for next 5-7 years period. Our 9x Forward PE multiple assigned to Solar falls on conservative side. Solar is the most attractively priced among peers (both domestic as well as global) compared to returns it has offered to its shareholders."
Buy Solar Industries India; target of Rs 52: KRChoksey
ALSO READ
* See previous views by KRChoksey
* See what other Experts & Brokerages are saying about Solar Ind
* See messages about Solar Ind
"Gross sales are growing at 23% CAGR from FY10-FY13E due to 33.2% growth in explosives business. Operation of explosive plant in Africa is leading to high growth in explosives sales. This is also shifting revenue mix in favour of explosives (from 59.9% in FY10 to 76.3% in FY13E. Realisation from African market is almost 2.5x Indian market. We recommend STRONG BUY on Solar Industries with 1 year price target of Rs 631.65, which gives potential upside of 39% from CMP of Rs 455,†says KRChoksey research report.
For more stock tips, news and many more visit STOCKINDIA TIPS WORLD
Earn Credits Worth Rs 50 On Dealivore By Referring Friends And Help Your Friends Get Rs 50 On Dealivore @ WWW.DEALIVORE.COM NOW
From: http://www.moneycontrol.com/news/recommendations/buy-solar-industries-india-targetrs-52-krchoksey_482651.html
SEARCH THIS SITE FOR MORE TIPS AND STOCK NEWS